NORTHERN TRUST CORP - CONTEXT THERAPEUTICS INC ownership

CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 24 filers reported holding CONTEXT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$56,201
-5.6%
37,2190.0%0.00%
Q2 2023$59,550
+184.6%
37,2190.0%0.00%
Q1 2023$20,925
-13.7%
37,2190.0%0.00%
Q4 2022$24,256
-6.7%
37,219
+60.4%
0.00%
Q3 2022$26,000
-46.9%
23,2000.0%0.00%
Q2 2022$49,00023,2000.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,165,100$2,528,0000.38%
Worth Venture Partners, LLC 317,729$689,0000.32%
Affinity Asset Advisors, LLC 777,610$1,687,0000.27%
Knoll Capital Management, LLC 139,520$303,0000.19%
swisspartners Ltd. 42,235$92,0000.07%
Veritable, L.P. 110,249$239,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 49,912$108,0000.00%
MORGAN STANLEY 10,000$22,0000.00%
BlackRock Inc. 16,961$37,0000.00%
Citadel Advisors 18,516$40,0000.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders